Valuation: OptimizeRx Corporation

Market Cap 175M 157M 145M 132M 246M 16.68B 249M 1.74B 692M 8.73B 657M 643M 27.72B P/E 2026 *
41.6x
P/E 2027 * 21.3x
Enterprise Value 175M 157M 145M 132M 246M 16.68B 249M 1.74B 692M 8.73B 657M 643M 27.72B EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.64x
Free-Float
78.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.81%
1 week-0.75%
Current month+11.38%
1 month+19.08%
3 months+46.69%
6 months+45.31%
Current year-24.14%
1 week 8.89
Extreme 8.89
9.46
1 month 8.11
Extreme 8.11
9.6
Current year 4.54
Extreme 4.54
14.16
1 year 4.54
Extreme 4.54
21.09
3 years 3.78
Extreme 3.78
22.25
5 years 3.78
Extreme 3.78
98.57
10 years 1.89
Extreme 1.890018
99.18
Manager TitleAgeSince
Chief Executive Officer 48 2024-12-30
Director of Finance/CFO 60 2021-10-10
Chief Operating Officer - 2025-08-17
Director TitleAgeSince
Director/Board Member 61 2017-01-11
Chairman 70 2024-01-23
Director/Board Member 70 2018-03-26
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Tax

Investor Relations Manager

-414 0.0022%
9/1/26 Tax

Investor Relations Manager

-1,432 0.0076%
8/21/26 Tax

Investor Relations Manager

-1,243 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
+2.65%-0.75%-55.80%+21.57% 171M
+1.34%-2.95%+21.47%+165.93% 3,900B
-1.24%-12.19%-18.49%+106.41% 1,585B
+0.08%-1.98%+7.84%+67.63% 534B
-1.70%-0.47%-41.54%+28.84% 442B
-0.85%-4.69%-43.77%+55.80% 257B
+0.72%-3.30%-42.87%+21.90% 249B
+1.45%-3.48%-6.00%+262.54% 213B
-0.78%-3.48%-31.60%+58.31% 134B
-3.07%+2.49%-17.60%+237.87% 114B
Average -1.53%-3.65%-22.84%+102.68% 742.91B
Weighted average by Cap. -5.30%-5.05%+1.45%+131.31%

Financials

2026 *2027 *
Net sales 96.23M 86.34M 79.82M 72.29M 135M 9.16B 137M 954M 380M 4.8B 361M 353M 15.23B 107M 95.64M 88.42M 80.08M 150M 10.15B 151M 1.06B 421M 5.31B 400M 392M 16.87B
Net income 4.92M 4.41M 4.08M 3.69M 6.9M 468M 6.98M 48.75M 19.42M 245M 18.45M 18.06M 778M 8.9M 7.99M 7.39M 6.69M 12.5M 848M 12.65M 88.31M 35.17M 444M 33.41M 32.71M 1.41B
Net Debt - -
Projected Income Statement - Annual - OptimizeRx Corporation
Logo OptimizeRx Corporation
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Employees
133
Date Price Change Volume
26-10-28 US$9.300 +2.65% 97,168
26-10-27 US$9.060 -0.11% 107,032
26-10-26 US$9.070 -0.87% 141,836
26-10-23 US$9.150 +0.77% 77,100
26-10-22 US$9.080 -3.09% 134,281
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - OptimizeRx Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.300USD
Average target price
12.60USD
Spread / Average Target
+35.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OptimizeRx Corporation
  1. Stock Market
  2. Stocks
  3. OPRX Stock